Heart Rate Control in Atrial Fibrillation
Beta blockers are the first-line treatment for lowering heart rate in patients with atrial fibrillation, with metoprolol being an excellent choice at a dose of 25-100 mg twice daily orally. 1
First-Line Medications for Heart Rate Control
Beta Blockers
- Beta blockers are the most effective drug class for rate control, achieving heart rate endpoints in 70% of patients compared to 54% with calcium channel blockers 1
- For immediate rate control, intravenous beta blockers are recommended:
- For long-term oral therapy:
Nondihydropyridine Calcium Channel Antagonists
- Consider as alternative first-line agents, especially in patients with bronchospasm or COPD 1
- Diltiazem: 120-360 mg once daily (extended release) 1
- Verapamil: 180-480 mg once daily (extended release) 1
- These agents have been associated with improved quality of life and exercise tolerance 1
- Caution: Should not be used in patients with decompensated heart failure 1
Second-Line Options
Digoxin
- Consider in patients with heart failure or left ventricular dysfunction 1
- Dosing: 0.125-0.375 mg daily orally 1
- Limitations: Less effective during exercise or states of high sympathetic tone 1
- Not recommended as sole agent for rate control in paroxysmal AF 1
Amiodarone
- Consider when other measures are unsuccessful or contraindicated 1
- Oral dosing: 100-200 mg daily 1
- IV dosing (for critically ill patients): 300 mg IV over 1 hour, then 10-50 mg/hour 1
- Caution: Significant long-term toxicity concerns including pulmonary toxicity, thyroid dysfunction, and skin discoloration 1
Target Heart Rate Goals
- Strict rate control (resting heart rate <80 bpm) is reasonable for symptomatic management 1
- Lenient rate control (resting heart rate <110 bpm) may be reasonable in asymptomatic patients with preserved left ventricular function 1
- Heart rate should be assessed during both rest and exertion, with medication adjusted accordingly 1, 3
Special Considerations
Heart Failure
- Beta blockers should be initiated cautiously in patients with heart failure and reduced ejection fraction 1
- For acute rate control in heart failure patients, IV digoxin or amiodarone is recommended 1
- A combination of digoxin and a beta blocker is reasonable to control both resting and exercise heart rate 1
Pre-excitation Syndromes
- Avoid digoxin, nondihydropyridine calcium channel antagonists, and amiodarone in patients with AF and pre-excitation syndromes 1
- These medications may paradoxically accelerate ventricular response 1
Monitoring and Follow-up
- Assess heart rate control during both rest and exercise 1
- Monitor for bradycardia, heart block, and hypotension, especially in elderly patients 1
- For beta blockers, start at a low dose and titrate up gradually to avoid bradycardia and hypotension 1
- If one agent is insufficient, consider combination therapy (e.g., beta blocker plus digoxin) 1